ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

Extramural Advisory Board Members Listed

October 20, 1995

In Brief: Allegheny Wins NSABP Recompetition; Luri Cancer Center Hosts Princess Diana

June 14, 1996

ONF Invites Applications for Fatigue Research

April 19, 1996

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990